IL139574A0 - TNF-RII (p75) AGONISTS FOR TREATING ASTHMA AND OTHER ALLERGIC CONDITIONS - Google Patents

TNF-RII (p75) AGONISTS FOR TREATING ASTHMA AND OTHER ALLERGIC CONDITIONS

Info

Publication number
IL139574A0
IL139574A0 IL13957498A IL13957498A IL139574A0 IL 139574 A0 IL139574 A0 IL 139574A0 IL 13957498 A IL13957498 A IL 13957498A IL 13957498 A IL13957498 A IL 13957498A IL 139574 A0 IL139574 A0 IL 139574A0
Authority
IL
Israel
Prior art keywords
rii
tnf
agonists
treating asthma
allergic conditions
Prior art date
Application number
IL13957498A
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL139574A0 publication Critical patent/IL139574A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL13957498A 1998-05-18 1998-05-18 TNF-RII (p75) AGONISTS FOR TREATING ASTHMA AND OTHER ALLERGIC CONDITIONS IL139574A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1998/000761 WO1999059632A1 (en) 1998-05-18 1998-05-18 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions

Publications (1)

Publication Number Publication Date
IL139574A0 true IL139574A0 (en) 2002-02-10

Family

ID=11004717

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13957498A IL139574A0 (en) 1998-05-18 1998-05-18 TNF-RII (p75) AGONISTS FOR TREATING ASTHMA AND OTHER ALLERGIC CONDITIONS

Country Status (6)

Country Link
EP (1) EP1077723A1 (en)
JP (1) JP2002515459A (en)
AU (1) AU7073898A (en)
CA (1) CA2328509A1 (en)
IL (1) IL139574A0 (en)
WO (1) WO1999059632A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7628988B2 (en) * 2002-06-27 2009-12-08 The General Hospital Corporation Methods and compositions for treating type 1 diabetes
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
JP6367836B2 (en) 2013-02-07 2018-08-01 ザ ジェネラル ホスピタル コーポレイション Method for proliferation or depletion of T regulatory cells
ES2699410T3 (en) * 2014-05-28 2019-02-11 Univ Dresden Tech Cell-based assay and methods of screening modulators of p75NTR signaling
US20180036404A1 (en) 2015-03-02 2018-02-08 180 Therapeutics Lp Method of treating a localized fibrotic disorder using a tnf receptor 2 antagonist
FI3447075T3 (en) 2015-05-15 2023-11-07 Massachusetts Gen Hospital Antagonistic anti-tumor necrosis factor receptor superfamily antibodies
US11266730B2 (en) 2015-09-29 2022-03-08 The General Hospital Corporation Methods of treating and diagnosing disease using biomarkers for BCG therapy
AU2017263833B2 (en) 2016-05-13 2023-08-03 The General Hospital Corporation Antagonistic anti-tumor necrosis factor receptor superfamily antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE119942T1 (en) * 1989-05-18 1995-04-15 Yeda Res & Dev TUMOR NECROSE FACTOR BINDING PROTEIN II, ITS PURIFICATION AND SPECIFIC ANTIBODIES.
IL107267A (en) * 1993-10-12 2009-07-20 Yeda Res & Dev Ligand to a member of the tnf/ngf receptor family
IL106271A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Ligand to the p75 tnf receptor and its preparation
WO1994009137A1 (en) * 1992-10-15 1994-04-28 Genentech, Inc. Antibodies against type 2 tumor necrosis factor receptor

Also Published As

Publication number Publication date
JP2002515459A (en) 2002-05-28
WO1999059632A1 (en) 1999-11-25
CA2328509A1 (en) 1999-11-25
EP1077723A1 (en) 2001-02-28
AU7073898A (en) 1999-12-06

Similar Documents

Publication Publication Date Title
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
PL348817A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2593900A (en) Composition and method for treating glaucoma
PH31420A (en) Methods of use for inhibiting bone loss and lowering serum cholesteol.
IL132133A0 (en) Method and composition for treating sleep apnea
IL115405A0 (en) Compositions and methods for treating mast-cell mediated conditions
HU9602951D0 (en) Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
EP1109580A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1115286A4 (en) Methods for treating or preventing viral infections and associated diseases
EP0915847A4 (en) Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
GB9521537D0 (en) Device and method for the treatment of sleep apnea syndrome
EP1143987A4 (en) Natural composition and method for the treatment of sexual dysfunction
AU4868599A (en) Composition for and method of treating neurological disorders
EP1067940A4 (en) Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
AU4995999A (en) Treatment for schizophrenia and other dopamine system dysfunctions
AU1833699A (en) Device and method for treating parkinson's disease
PL345275A1 (en) Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
BG105437A (en) Rheoogy modified compositions and processes thereof
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
HUP0103842A3 (en) Method for the treatment of mania and bipolar disorder
ZA991053B (en) Method and composition for treatment of inflammatory conditions.
AU5838700A (en) Method for treating and preventing finger disorders
IL139574A0 (en) TNF-RII (p75) AGONISTS FOR TREATING ASTHMA AND OTHER ALLERGIC CONDITIONS
IL125557A0 (en) Use of lhrh-analogs and anti-estrogens for treating gynaecological disorders